SLU-PP-322
SLU-PP-322 — ERR alpha/gamma agonist that mimics the molecular signature of aerobic exercise, driving fat oxidation and mitochondrial gene expression without receptor desensitisation.
- Activates ERR-alpha and ERR-gamma — the nuclear receptors governing aerobic exercise gene expression
- Drives fat oxidation independent of AMPK — a complementary pathway to AICAR/MOTS-c
- Upregulates mitochondrial biogenesis and oxidative enzyme expression
- Improves running endurance and reduces fat mass in preclinical models
- Novel mechanism — does not share tolerance or downregulation profile with AMPK activators
Dosage Calculator
Reference dosing by experience level. For research use only — always consult a licensed healthcare provider.
⚠ For research reference only. SLU-PP-322 is not approved for human use. Always consult a qualified healthcare professional.
What's in the Box
Every Poptides order arrives in premium packaging, ready to use.
SLU-PP-322 Vial
Your selected amount of lyophilized SLU-PP-322 in a sealed, sterile glass vial with silver crimp cap. COA included on request.
BAC Water 3mL
Bacteriostatic water for reconstitution, included with every injectable peptide order. Maintains sterility for multi-dose use.
Syringe Kit
5 × insulin syringes with orange caps, individually sealed, in a dedicated Poptides-branded box.
Research Guide Card + Thank You Note
A QR code card linking to your product's research guide, plus a personal thank you note from the Poptides team.
Discreet Outer Packaging
All orders ship in plain, unmarked outer packaging with no reference to Poptides on the exterior.
How SLU-PP-322 Works
The mechanism of action, step by step.
ERR-alpha/gamma Agonism
SLU-PP-322 binds and activates Estrogen-Related Receptors alpha and gamma (ERR-alpha, ERR-gamma) — nuclear receptor transcription factors that regulate the expression of genes governing mitochondrial oxidative phosphorylation, fatty acid oxidation, and aerobic exercise adaptation.
PGC-1alpha Transcriptional Co-activation
ERR-alpha and ERR-gamma are the primary downstream partners of PGC-1alpha, the master regulator of mitochondrial biogenesis. SLU-PP-322 activates these receptors in a way that mimics the PGC-1alpha signalling produced by endurance exercise, driving an authentic aerobic gene expression program.
Fat Oxidation Enzyme Upregulation
ERR activation increases expression of key fat oxidation enzymes including CPT-1, HADHA, and ACADM. These regulate the transport and beta-oxidation of long-chain fatty acids in mitochondria — the fundamental molecular basis for improved fat burning capacity.
Complementary to AMPK Pathway
AICAR and MOTS-c work upstream through AMPK. SLU-PP-322 works downstream at the nuclear receptor level where exercise gene programs are transcribed. Combining them addresses both the cellular energy sensor (upstream) and the gene expression effector (downstream) — potentially synergistic for endurance and metabolic adaptation.
Research Protocol
Published preclinical dosing guidelines for reference.
The Science Behind It
Peer-reviewed research supporting the mechanism of SLU-PP-322.
SLU-PP-322 activates ERR-alpha/gamma and mimics aerobic exercise gene signature
SLU-PP-322 activated ERR-alpha and ERR-gamma transcriptional programs in skeletal muscle, producing gene expression changes that closely mirrored those induced by endurance exercise training, including upregulation of mitochondrial biogenesis and fatty acid oxidation pathways.
Nature Chemical Biology, 2023ERR agonist improves running endurance and reduces adiposity in mice
Mice treated with an ERR-alpha/gamma agonist showed significant increases in treadmill endurance performance and reductions in fat mass, with histological evidence of increased skeletal muscle mitochondrial density and oxidative fibre proportion.
Cell Metabolism, 2023Estrogen-related receptors as therapeutic targets for metabolic disease
ERR-alpha and ERR-gamma govern the transcriptional response to exercise in skeletal muscle and heart, making them high-value pharmacological targets for metabolic disease, sarcopenia, and heart failure — contexts where increasing mitochondrial function and fat oxidation is therapeutically beneficial.
Nature Reviews Drug Discovery, 2021Customer Reviews
Verified purchases from Canadian customers.
The newest frontier in metabolic peptides
The ERR mechanism is distinct from everything else I have used. After 6 weeks I can feel the difference in fat oxidation efficiency — both in fasted cardio performance and body composition trend. Stacking with AICAR.
Very early to judge but trend is positive
Only 4 weeks in. Endurance metrics are improving and body composition is trending favourably. The science on the ERR pathway is compelling. More data needed but initial n=1 result is encouraging.
Interesting compound for serious researchers
The 2023 Nature Chemical Biology paper is what convinced me to try this. Novel mechanism, preliminary but solid preclinical data. Treating it as frontier research — tracking biomarkers carefully.
Frequently Asked Questions
You May Also Like
SLU-PP-322